179 related articles for article (PubMed ID: 36710341)
1. Targeting epigenetic features in clear cell sarcomas based on patient-derived cell lines.
Karner C; Anders I; Vejzovic D; Szkandera J; Scheipl S; Deutsch AJA; Weiss L; Vierlinger K; Kolb D; Kühberger S; Heitzer E; Habisch H; Zhang F; Madl T; Reininger-Gutmann B; Liegl-Atzwanger B; Rinner B
J Transl Med; 2023 Jan; 21(1):54. PubMed ID: 36710341
[TBL] [Abstract][Full Text] [Related]
2. PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma.
Wang J; Wang C; Xu P; Li X; Lu Y; Jin D; Yin X; Jiang H; Huang J; Xiong H; Ye F; Jin J; Chen Y; Xie Y; Chen Z; Ding H; Zhang H; Liu R; Jiang H; Chen K; Yao Z; Luo C; Huang Y; Zhang Y; Zhang J
Theranostics; 2021; 11(11):5387-5403. PubMed ID: 33859753
[No Abstract] [Full Text] [Related]
3. Establishment of a novel clear cell sarcoma cell line (Hewga-CCS), and investigation of the antitumor effects of pazopanib on Hewga-CCS.
Outani H; Tanaka T; Wakamatsu T; Imura Y; Hamada K; Araki N; Itoh K; Yoshikawa H; Naka N
BMC Cancer; 2014 Jun; 14():455. PubMed ID: 24946937
[TBL] [Abstract][Full Text] [Related]
4. Establishment and Characterization of a Novel Human Clear-cell Sarcoma of Soft-tissue Cell Line, RSAR001, Derived from Pleural Effusion of a Patient with Pleural Dissemination.
Hakozaki M; Tamura H; Dobashi Y; Yoshida A; Kato K; Tajino T; Yamada H; Kaneuchi Y; Katahira K; Ezaki J; Waguri S; Konno S; Watanabe S
Anticancer Res; 2018 Sep; 38(9):5035-5042. PubMed ID: 30194147
[TBL] [Abstract][Full Text] [Related]
5. Establishment and proteomic characterization of patient-derived clear cell sarcoma xenografts and cell lines.
Sakumoto M; Oyama R; Takahashi M; Takai Y; Kito F; Shiozawa K; Qiao Z; Endo M; Yoshida A; Kawai A; Kondo T
In Vitro Cell Dev Biol Anim; 2018 Feb; 54(2):163-176. PubMed ID: 29197033
[TBL] [Abstract][Full Text] [Related]
6. PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD
He X; Zhu Y; Lin YC; Li M; Du J; Dong H; Sun J; Zhu L; Wang H; Ding Z; Zhang L; Zhang L; Zhao D; Wang Z; Wu H; Zhang H; Jiang W; Xu Y; Jin J; Shen Y; Perry J; Zhao X; Zhang B; Liu S; Xue SL; Shen B; Chen CW; Chen J; Khaled S; Kuo YH; Marcucci G; Luo Y; Li L
Blood; 2019 Aug; 134(6):548-560. PubMed ID: 31217189
[TBL] [Abstract][Full Text] [Related]
7. Methylation of C/EBPα by PRMT1 Inhibits Its Tumor-Suppressive Function in Breast Cancer.
Liu LM; Sun WZ; Fan XZ; Xu YL; Cheng MB; Zhang Y
Cancer Res; 2019 Jun; 79(11):2865-2877. PubMed ID: 31015230
[TBL] [Abstract][Full Text] [Related]
8. TLS and PRMT1 synergistically coactivate transcription at the survivin promoter through TLS arginine methylation.
Du K; Arai S; Kawamura T; Matsushita A; Kurokawa R
Biochem Biophys Res Commun; 2011 Jan; 404(4):991-6. PubMed ID: 21187067
[TBL] [Abstract][Full Text] [Related]
9. PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling.
Yao B; Gui T; Zeng X; Deng Y; Wang Z; Wang Y; Yang D; Li Q; Xu P; Hu R; Li X; Chen B; Wang J; Zen K; Li H; Davis MJ; Herold MJ; Pan HF; Jiang ZW; Huang DCS; Liu M; Ju J; Zhao Q
Genome Med; 2021 Apr; 13(1):58. PubMed ID: 33853662
[TBL] [Abstract][Full Text] [Related]
10. Arginine methylation by PRMT1 regulates nuclear-cytoplasmic localization and toxicity of FUS/TLS harbouring ALS-linked mutations.
Tradewell ML; Yu Z; Tibshirani M; Boulanger MC; Durham HD; Richard S
Hum Mol Genet; 2012 Jan; 21(1):136-49. PubMed ID: 21965298
[TBL] [Abstract][Full Text] [Related]
11. PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma.
Giuliani V; Miller MA; Liu CY; Hartono SR; Class CA; Bristow CA; Suzuki E; Sanz LA; Gao G; Gay JP; Feng N; Rose JL; Tomihara H; Daniele JR; Peoples MD; Bardenhagen JP; Geck Do MK; Chang QE; Vangamudi B; Vellano C; Ying H; Deem AK; Do KA; Genovese G; Marszalek JR; Kovacs JJ; Kim M; Fleming JB; Guccione E; Viale A; Maitra A; Emilia Di Francesco M; Yap TA; Jones P; Draetta G; Carugo A; Chedin F; Heffernan TP
Nat Commun; 2021 Jul; 12(1):4626. PubMed ID: 34330913
[TBL] [Abstract][Full Text] [Related]
12. Roles of protein arginine methyltransferase 1 (PRMT1) in brain development and disease.
Hashimoto M; Fukamizu A; Nakagawa T; Kizuka Y
Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129776. PubMed ID: 33127433
[TBL] [Abstract][Full Text] [Related]
13. Loss of the major Type I arginine methyltransferase PRMT1 causes substrate scavenging by other PRMTs.
Dhar S; Vemulapalli V; Patananan AN; Huang GL; Di Lorenzo A; Richard S; Comb MJ; Guo A; Clarke SG; Bedford MT
Sci Rep; 2013; 3():1311. PubMed ID: 23419748
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional down-regulation through nuclear exclusion of EWS methylated by PRMT1.
Araya N; Hiraga H; Kako K; Arao Y; Kato S; Fukamizu A
Biochem Biophys Res Commun; 2005 Apr; 329(2):653-60. PubMed ID: 15737635
[TBL] [Abstract][Full Text] [Related]
15. Discovery of alkyl bis(oxy)dibenzimidamide derivatives as novel protein arginine methyltransferase 1 (PRMT1) inhibitors.
Zhang WY; Lu WC; Jiang H; Lv ZB; Xie YQ; Lian FL; Liang ZJ; Jiang YX; Wang DJ; Luo C; Jin J; Ye F
Chem Biol Drug Des; 2017 Dec; 90(6):1260-1270. PubMed ID: 28636189
[TBL] [Abstract][Full Text] [Related]
16. The role of PRMT1 in EGFR methylation and signaling in MDA-MB-468 triple-negative breast cancer cells.
Nakai K; Xia W; Liao HW; Saito M; Hung MC; Yamaguchi H
Breast Cancer; 2018 Jan; 25(1):74-80. PubMed ID: 28643125
[TBL] [Abstract][Full Text] [Related]
17. Small molecule inhibitors that discriminate between protein arginine N-methyltransferases PRMT1 and CARM1.
Dowden J; Pike RA; Parry RV; Hong W; Muhsen UA; Ward SG
Org Biomol Chem; 2011 Oct; 9(22):7814-21. PubMed ID: 21952734
[TBL] [Abstract][Full Text] [Related]
18. PRMT1 promotes pancreatic cancer growth and predicts poor prognosis.
Song C; Chen T; He L; Ma N; Li JA; Rong YF; Fang Y; Liu M; Xie D; Lou W
Cell Oncol (Dordr); 2020 Feb; 43(1):51-62. PubMed ID: 31520395
[TBL] [Abstract][Full Text] [Related]
19. Cholecalciferol and metformin protect against lipopolysaccharide-induced endothelial dysfunction and senescence by modulating sirtuin-1 and protein arginine methyltransferase-1.
Raj V; Natarajan S; C M; Chatterjee S; Ramasamy M; Ramanujam GM; Arasu MV; Al-Dhabi NA; Choi KC; Arockiaraj J; Karuppiah K
Eur J Pharmacol; 2021 Dec; 912():174531. PubMed ID: 34710370
[TBL] [Abstract][Full Text] [Related]
20. A novel splicing isoform of protein arginine methyltransferase 1 (PRMT1) that lacks the dimerization arm and correlates with cellular malignancy.
Patounas O; Papacharalampous I; Eckerich C; Markopoulos GS; Kolettas E; Fackelmayer FO
J Cell Biochem; 2018 Feb; 119(2):2110-2123. PubMed ID: 28857308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
